As most PTCs are also associated with severe loss of CFTR transcripts, significant efforts are invested into non-specific and gene-specific NMD suppression in CF (de Poel et al., 2022; Kim et al., 2022). The gene discussed is CFTR; the disease is cystic fibrosis.